Quick Answer
Eledon Pharmaceuticals, Inc. reported Stockholders Equity of $81.08 million for fiscal year 2025.
Eledon Pharmaceuticals, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $81.08M | +29.8% |
| 2024 | $62.45M | +228.8% |
| 2023 | -$48.49M | -157.6% |
| 2022 | $84.18M | -48.7% |
| 2021 | $164.00M | -14.0% |
| 2020 | $190.60M | +1913.7% |
| 2019 | $9.46M | -34.7% |
| 2018 | $14.49M | -25.5% |
| 2017 | $19.45M | +819.9% |
| 2016 | -$2.70M | -197.1% |
| 2015 | $2.78M | -97.3% |
| 2014 | $103.50M | +287.3% |
| 2013 | -$55.27M | -38.5% |
| 2012 | -$39.90M | -31.1% |
| 2011 | -$30.43M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $35.36M | +73.6% | -29.7% |
| June 30, 2025 | $50.33M | +178.4% | -14.5% |
| March 31, 2025 | $58.89M | +183.6% | -5.7% |
| December 31, 2024 | $62.45M | +228.8% | +206.6% |
| September 30, 2024 | $20.36M | -42.8% | +131.7% |
| June 30, 2024 | -$64.19M | -246.7% | +8.8% |
| March 31, 2024 | -$70.42M | -194.2% | -45.2% |
| December 31, 2023 | -$48.49M | -157.6% | -236.2% |
- Eledon Pharmaceuticals, Inc. showed an increase of +29.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2011–2025 period, Eledon Pharmaceuticals, Inc.’s stockholders equity has grown by 366.4% (from -$30.43 million to $81.08 million).
- The most recent figure is from Eledon Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: